ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
  • Category
  • Region
U.S. (TOLL FREE)
+1 (315) 215-3225
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Liraglutide Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
Published Date: March 2025
|
Report Code: QYRE-Auto-29O4198
Home | Market Reports | Health| Health Foundations & Medical Research
Global Liraglutide Market Research Report 2021
BUY CHAPTERS

Global Liraglutide Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Code: QYRE-Auto-29O4198
Report
March 2025
Pages:76
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
HEC Pharm
Bachem
Bharat Pharmaceuticals
Kingpep Biotechnology
Shenzhen JYMed Technology
Wuxi Asiapeptide
AmbioPharm

Liraglutide Sales Market

The global Liraglutide market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Liraglutide (NN2211) is a long-acting glucagon-like peptide-1 receptor agonist, binding to the same receptors as does the endogenous metabolic hormone GLP-1 that stimulates insulin secretion. Marketed under the brand name Victoza, it is an injectable drug developed by Novo Nordisk for the treatment of type 2 diabetes. In 2015, Novo Nordisk began marketing it in the U.S. under the brand name Saxenda as a treatment for obesity in adults with at least one weight-related comorbid condition.
The North America Liraglutide market size was US$ million in 2024, while Europe was US$ million. The proportion of the North America was % in 2024, while Europe percentage was %, and it is predicted that Europe share will reach % in 2031, trailing a CAGR of % through the analysis period.
The global key manufacturers of Liraglutide include HEC Pharm, Bachem, Bharat Pharmaceuticals, Kingpep Biotechnology, Shenzhen JYMed Technology, Wuxi Asiapeptide, AmbioPharm, etc. In 2024, the global top five players occupied for a share approximately % in terms of revenue.
In North America, in terms of sales volume, in 2024, the top three players hold a share about %, while in Europe, top three players hold a share nearly %.
The global Liraglutide market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation

Scope of Liraglutide Sales Market Report

Report Metric Details
Report Name Liraglutide Sales Market
By Type: (Dominant Segment vs High-Margin Innovation)
  • Pills
  • Liquid
By Application: (Core Demand Driver vs Emerging Opportunity)
  • Hospital
  • Drug Store
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company: HEC Pharm, Bachem, Bharat Pharmaceuticals, Kingpep Biotechnology, Shenzhen JYMed Technology, Wuxi Asiapeptide, AmbioPharm
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
  • Chapter 2: Quantitative analysis of Liraglutide market size and growth potential at global, regional, and country levels.
  • Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
  • Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Liquid in China).
  • Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Drug Store in India).
  • Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
  • Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
  • Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 9: Actionable conclusions and strategic recommendations.
  • Why This Report?
  • This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:
  • - Risk-Controlled Market Entry: Navigate regulatory complexities in focus markets (e.g., China’s policies).
  • - Product Portfolio Optimization: Align offerings with regional preferences (e.g., Pills dominance in Europe vs. Liquid demand in MEA).
  • - Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.

FAQ for this report

Who are the main players in the Liraglutide Sales Market report?

Ans: The main players in the Liraglutide Sales Market are HEC Pharm, Bachem, Bharat Pharmaceuticals, Kingpep Biotechnology, Shenzhen JYMed Technology, Wuxi Asiapeptide, AmbioPharm

What are the Application segmentation covered in the Liraglutide Sales Market report?

Ans: The Applications covered in the Liraglutide Sales Market report are Hospital, Drug Store

What are the Type segmentation covered in the Liraglutide Sales Market report?

Ans: The Types covered in the Liraglutide Sales Market report are Pills, Liquid

1 Market Overview
1.1 Liraglutide Product Scope
1.2 Liraglutide by Type
1.2.1 Global Liraglutide Sales by Type (2020 & 2024 & 2031)
1.2.2 Pills
1.2.3 Liquid
1.3 Liraglutide by Application
1.3.1 Global Liraglutide Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Hospital
1.3.3 Drug Store
1.4 Global Liraglutide Market Estimates and Forecasts (2020-2031)
1.4.1 Global Liraglutide Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Liraglutide Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Liraglutide Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Liraglutide Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Liraglutide Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Liraglutide Sales Market Share by Region (2020-2025)
2.2.2 Global Liraglutide Revenue Market Share by Region (2020-2025)
2.3 Global Liraglutide Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Liraglutide Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Liraglutide Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Liraglutide Market Size and Prospective (2020-2031)
2.4.2 Europe Liraglutide Market Size and Prospective (2020-2031)
2.4.3 China Liraglutide Market Size and Prospective (2020-2031)
2.4.4 Japan Liraglutide Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Liraglutide Historic Market Review by Type (2020-2025)
3.1.1 Global Liraglutide Sales by Type (2020-2025)
3.1.2 Global Liraglutide Revenue by Type (2020-2025)
3.1.3 Global Liraglutide Price by Type (2020-2025)
3.2 Global Liraglutide Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Liraglutide Sales Forecast by Type (2026-2031)
3.2.2 Global Liraglutide Revenue Forecast by Type (2026-2031)
3.2.3 Global Liraglutide Price Forecast by Type (2026-2031)
3.3 Different Types Liraglutide Representative Players
4 Global Market Size by Application
4.1 Global Liraglutide Historic Market Review by Application (2020-2025)
4.1.1 Global Liraglutide Sales by Application (2020-2025)
4.1.2 Global Liraglutide Revenue by Application (2020-2025)
4.1.3 Global Liraglutide Price by Application (2020-2025)
4.2 Global Liraglutide Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Liraglutide Sales Forecast by Application (2026-2031)
4.2.2 Global Liraglutide Revenue Forecast by Application (2026-2031)
4.2.3 Global Liraglutide Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Liraglutide Application
5 Competition Landscape by Players
5.1 Global Liraglutide Sales by Players (2020-2025)
5.2 Global Top Liraglutide Players by Revenue (2020-2025)
5.3 Global Liraglutide Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liraglutide as of 2024)
5.4 Global Liraglutide Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Liraglutide, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Liraglutide, Product Type & Application
5.7 Global Key Manufacturers of Liraglutide, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Liraglutide Sales by Company
6.1.1.1 North America Liraglutide Sales by Company (2020-2025)
6.1.1.2 North America Liraglutide Revenue by Company (2020-2025)
6.1.2 North America Liraglutide Sales Breakdown by Type (2020-2025)
6.1.3 North America Liraglutide Sales Breakdown by Application (2020-2025)
6.1.4 North America Liraglutide Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Liraglutide Sales by Company
6.2.1.1 Europe Liraglutide Sales by Company (2020-2025)
6.2.1.2 Europe Liraglutide Revenue by Company (2020-2025)
6.2.2 Europe Liraglutide Sales Breakdown by Type (2020-2025)
6.2.3 Europe Liraglutide Sales Breakdown by Application (2020-2025)
6.2.4 Europe Liraglutide Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Liraglutide Sales by Company
6.3.1.1 China Liraglutide Sales by Company (2020-2025)
6.3.1.2 China Liraglutide Revenue by Company (2020-2025)
6.3.2 China Liraglutide Sales Breakdown by Type (2020-2025)
6.3.3 China Liraglutide Sales Breakdown by Application (2020-2025)
6.3.4 China Liraglutide Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Liraglutide Sales by Company
6.4.1.1 Japan Liraglutide Sales by Company (2020-2025)
6.4.1.2 Japan Liraglutide Revenue by Company (2020-2025)
6.4.2 Japan Liraglutide Sales Breakdown by Type (2020-2025)
6.4.3 Japan Liraglutide Sales Breakdown by Application (2020-2025)
6.4.4 Japan Liraglutide Major Customer
6.4.5 Japan Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 HEC Pharm
7.1.1 HEC Pharm Company Information
7.1.2 HEC Pharm Business Overview
7.1.3 HEC Pharm Liraglutide Sales, Revenue and Gross Margin (2020-2025)
7.1.4 HEC Pharm Liraglutide Products Offered
7.1.5 HEC Pharm Recent Development
7.2 Bachem
7.2.1 Bachem Company Information
7.2.2 Bachem Business Overview
7.2.3 Bachem Liraglutide Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Bachem Liraglutide Products Offered
7.2.5 Bachem Recent Development
7.3 Bharat Pharmaceuticals
7.3.1 Bharat Pharmaceuticals Company Information
7.3.2 Bharat Pharmaceuticals Business Overview
7.3.3 Bharat Pharmaceuticals Liraglutide Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Bharat Pharmaceuticals Liraglutide Products Offered
7.3.5 Bharat Pharmaceuticals Recent Development
7.4 Kingpep Biotechnology
7.4.1 Kingpep Biotechnology Company Information
7.4.2 Kingpep Biotechnology Business Overview
7.4.3 Kingpep Biotechnology Liraglutide Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Kingpep Biotechnology Liraglutide Products Offered
7.4.5 Kingpep Biotechnology Recent Development
7.5 Shenzhen JYMed Technology
7.5.1 Shenzhen JYMed Technology Company Information
7.5.2 Shenzhen JYMed Technology Business Overview
7.5.3 Shenzhen JYMed Technology Liraglutide Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Shenzhen JYMed Technology Liraglutide Products Offered
7.5.5 Shenzhen JYMed Technology Recent Development
7.6 Wuxi Asiapeptide
7.6.1 Wuxi Asiapeptide Company Information
7.6.2 Wuxi Asiapeptide Business Overview
7.6.3 Wuxi Asiapeptide Liraglutide Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Wuxi Asiapeptide Liraglutide Products Offered
7.6.5 Wuxi Asiapeptide Recent Development
7.7 AmbioPharm
7.7.1 AmbioPharm Company Information
7.7.2 AmbioPharm Business Overview
7.7.3 AmbioPharm Liraglutide Sales, Revenue and Gross Margin (2020-2025)
7.7.4 AmbioPharm Liraglutide Products Offered
7.7.5 AmbioPharm Recent Development
8 Liraglutide Manufacturing Cost Analysis
8.1 Liraglutide Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Liraglutide
8.4 Liraglutide Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Liraglutide Distributors List
9.3 Liraglutide Customers
10 Liraglutide Market Dynamics
10.1 Liraglutide Industry Trends
10.2 Liraglutide Market Drivers
10.3 Liraglutide Market Challenges
10.4 Liraglutide Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
FEATURED COMPANIES
HEC Pharm
Bachem
Bharat Pharmaceuticals
Kingpep Biotechnology
Shenzhen JYMed Technology
Wuxi Asiapeptide
AmbioPharm
List of Tables
 Table 1. Global Liraglutide Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
 Table 2. Global Liraglutide Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
 Table 3. Global Market Liraglutide Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
 Table 4. Global Liraglutide Sales (K MT) by Region (2020-2025)
 Table 5. Global Liraglutide Sales Market Share by Region (2020-2025)
 Table 6. Global Liraglutide Revenue (US$ Million) Market Share by Region (2020-2025)
 Table 7. Global Liraglutide Revenue Share by Region (2020-2025)
 Table 8. Global Liraglutide Sales (K MT) Forecast by Region (2026-2031)
 Table 9. Global Liraglutide Sales Market Share Forecast by Region (2026-2031)
 Table 10. Global Liraglutide Revenue (US$ Million) Forecast by Region (2026-2031)
 Table 11. Global Liraglutide Revenue Share Forecast by Region (2026-2031)
 Table 12. Global Liraglutide Sales by Type (K MT) & (2020-2025)
 Table 13. Global Liraglutide Sales Share by Type (2020-2025)
 Table 14. Global Liraglutide Revenue by Type (US$ Million) & (2020-2025)
 Table 15. Global Liraglutide Price by Type (USD/MT) & (2020-2025)
 Table 16. Global Liraglutide Sales by Type (K MT) & (2026-2031)
 Table 17. Global Liraglutide Revenue by Type (US$ Million) & (2026-2031)
 Table 18. Global Liraglutide Price by Type (USD/MT) & (2026-2031)
 Table 19. Representative Players of Each Type
 Table 20. Global Liraglutide Sales by Application (K MT) & (2020-2025)
 Table 21. Global Liraglutide Sales Share by Application (2020-2025)
 Table 22. Global Liraglutide Revenue by Application (US$ Million) & (2020-2025)
 Table 23. Global Liraglutide Price by Application (USD/MT) & (2020-2025)
 Table 24. Global Liraglutide Sales by Application (K MT) & (2026-2031)
 Table 25. Global Liraglutide Revenue Market Share by Application (US$ Million) & (2026-2031)
 Table 26. Global Liraglutide Price by Application (USD/MT) & (2026-2031)
 Table 27. New Sources of Growth in Liraglutide Application
 Table 28. Global Liraglutide Sales by Company (K MT) & (2020-2025)
 Table 29. Global Liraglutide Sales Share by Company (2020-2025)
 Table 30. Global Liraglutide Revenue by Company (US$ Million) & (2020-2025)
 Table 31. Global Liraglutide Revenue Share by Company (2020-2025)
 Table 32. Global Liraglutide by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liraglutide as of 2024)
 Table 33. Global Market Liraglutide Average Price by Company (USD/MT) & (2020-2025)
 Table 34. Global Key Manufacturers of Liraglutide, Manufacturing Sites & Headquarters
 Table 35. Global Key Manufacturers of Liraglutide, Product Type & Application
 Table 36. Global Key Manufacturers of Liraglutide, Date of Enter into This Industry
 Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 38. North America Liraglutide Sales by Company (2020-2025) & (K MT)
 Table 39. North America Liraglutide Sales Market Share by Company (2020-2025)
 Table 40. North America Liraglutide Revenue by Company (2020-2025) & (US$ Million)
 Table 41. North America Liraglutide Revenue Market Share by Company (2020-2025)
 Table 42. North America Liraglutide Sales by Type (2020-2025) & (K MT)
 Table 43. North America Liraglutide Sales Market Share by Type (2020-2025)
 Table 44. North America Liraglutide Sales by Application (2020-2025) & (K MT)
 Table 45. North America Liraglutide Sales Market Share by Application (2020-2025)
 Table 46. Europe Liraglutide Sales by Company (2020-2025) & (K MT)
 Table 47. Europe Liraglutide Sales Market Share by Company (2020-2025)
 Table 48. Europe Liraglutide Revenue by Company (2020-2025) & (US$ Million)
 Table 49. Europe Liraglutide Revenue Market Share by Company (2020-2025)
 Table 50. Europe Liraglutide Sales by Type (2020-2025) & (K MT)
 Table 51. Europe Liraglutide Sales Market Share by Type (2020-2025)
 Table 52. Europe Liraglutide Sales by Application (2020-2025) & (K MT)
 Table 53. Europe Liraglutide Sales Market Share by Application (2020-2025)
 Table 54. China Liraglutide Sales by Company (2020-2025) & (K MT)
 Table 55. China Liraglutide Sales Market Share by Company (2020-2025)
 Table 56. China Liraglutide Revenue by Company (2020-2025) & (US$ Million)
 Table 57. China Liraglutide Revenue Market Share by Company (2020-2025)
 Table 58. China Liraglutide Sales by Type (2020-2025) & (K MT)
 Table 59. China Liraglutide Sales Market Share by Type (2020-2025)
 Table 60. China Liraglutide Sales by Application (2020-2025) & (K MT)
 Table 61. China Liraglutide Sales Market Share by Application (2020-2025)
 Table 62. Japan Liraglutide Sales by Company (2020-2025) & (K MT)
 Table 63. Japan Liraglutide Sales Market Share by Company (2020-2025)
 Table 64. Japan Liraglutide Revenue by Company (2020-2025) & (US$ Million)
 Table 65. Japan Liraglutide Revenue Market Share by Company (2020-2025)
 Table 66. Japan Liraglutide Sales by Type (2020-2025) & (K MT)
 Table 67. Japan Liraglutide Sales Market Share by Type (2020-2025)
 Table 68. Japan Liraglutide Sales by Application (2020-2025) & (K MT)
 Table 69. Japan Liraglutide Sales Market Share by Application (2020-2025)
 Table 70. HEC Pharm Company Information
 Table 71. HEC Pharm Description and Business Overview
 Table 72. HEC Pharm Liraglutide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 73. HEC Pharm Liraglutide Product
 Table 74. HEC Pharm Recent Development
 Table 75. Bachem Company Information
 Table 76. Bachem Description and Business Overview
 Table 77. Bachem Liraglutide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 78. Bachem Liraglutide Product
 Table 79. Bachem Recent Development
 Table 80. Bharat Pharmaceuticals Company Information
 Table 81. Bharat Pharmaceuticals Description and Business Overview
 Table 82. Bharat Pharmaceuticals Liraglutide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 83. Bharat Pharmaceuticals Liraglutide Product
 Table 84. Bharat Pharmaceuticals Recent Development
 Table 85. Kingpep Biotechnology Company Information
 Table 86. Kingpep Biotechnology Description and Business Overview
 Table 87. Kingpep Biotechnology Liraglutide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 88. Kingpep Biotechnology Liraglutide Product
 Table 89. Kingpep Biotechnology Recent Development
 Table 90. Shenzhen JYMed Technology Company Information
 Table 91. Shenzhen JYMed Technology Description and Business Overview
 Table 92. Shenzhen JYMed Technology Liraglutide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 93. Shenzhen JYMed Technology Liraglutide Product
 Table 94. Shenzhen JYMed Technology Recent Development
 Table 95. Wuxi Asiapeptide Company Information
 Table 96. Wuxi Asiapeptide Description and Business Overview
 Table 97. Wuxi Asiapeptide Liraglutide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 98. Wuxi Asiapeptide Liraglutide Product
 Table 99. Wuxi Asiapeptide Recent Development
 Table 100. AmbioPharm Company Information
 Table 101. AmbioPharm Description and Business Overview
 Table 102. AmbioPharm Liraglutide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 103. AmbioPharm Liraglutide Product
 Table 104. AmbioPharm Recent Development
 Table 105. Production Base and Market Concentration Rate of Raw Material
 Table 106. Key Suppliers of Raw Materials
 Table 107. Liraglutide Distributors List
 Table 108. Liraglutide Customers List
 Table 109. Liraglutide Market Trends
 Table 110. Liraglutide Market Drivers
 Table 111. Liraglutide Market Challenges
 Table 112. Liraglutide Market Restraints
 Table 113. Research Programs/Design for This Report
 Table 114. Key Data Information from Secondary Sources
 Table 115. Key Data Information from Primary Sources


List of Figures
 Figure 1. Liraglutide Product Picture
 Figure 2. Global Liraglutide Sales (US$ Million) by Type (2020 & 2024 & 2031)
 Figure 3. Global Liraglutide Sales Market Share by Type in 2024 & 2031
 Figure 4. Pills Product Picture
 Figure 5. Liquid Product Picture
 Figure 6. Global Liraglutide Sales (US$ Million) by Application (2020 & 2024 & 2031)
 Figure 7. Global Liraglutide Sales Market Share by Application in 2024 & 2031
 Figure 8. Hospital Examples
 Figure 9. Drug Store Examples
 Figure 10. Global Liraglutide Sales, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Liraglutide Sales Growth Rate (2020-2031) & (US$ Million)
 Figure 12. Global Liraglutide Sales (K MT) Growth Rate (2020-2031)
 Figure 13. Global Liraglutide Price Trends Growth Rate (2020-2031) & (USD/MT)
 Figure 14. Liraglutide Report Years Considered
 Figure 15. Global Market Liraglutide Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
 Figure 16. Global Liraglutide Revenue Market Share by Region: 2020 VS 2024
 Figure 17. North America Liraglutide Revenue (US$ Million) Growth Rate (2020-2031)
 Figure 18. North America Liraglutide Sales (K MT) Growth Rate (2020-2031)
 Figure 19. Europe Liraglutide Revenue (US$ Million) Growth Rate (2020-2031)
 Figure 20. Europe Liraglutide Sales (K MT) Growth Rate (2020-2031)
 Figure 21. China Liraglutide Revenue (US$ Million) Growth Rate (2020-2031)
 Figure 22. China Liraglutide Sales (K MT) Growth Rate (2020-2031)
 Figure 23. Japan Liraglutide Revenue (US$ Million) Growth Rate (2020-2031)
 Figure 24. Japan Liraglutide Sales (K MT) Growth Rate (2020-2031)
 Figure 25. Global Liraglutide Revenue Share by Type (2020-2025)
 Figure 26. Global Liraglutide Sales Share by Type (2026-2031)
 Figure 27. Global Liraglutide Revenue Share by Type (2026-2031)
 Figure 28. Global Liraglutide Revenue Share by Application (2020-2025)
 Figure 29. Global Liraglutide Revenue Growth Rate by Application in 2020 & 2024
 Figure 30. Global Liraglutide Sales Share by Application (2026-2031)
 Figure 31. Global Liraglutide Revenue Share by Application (2026-2031)
 Figure 32. Global Liraglutide Sales Share by Company (2024)
 Figure 33. Global Liraglutide Revenue Share by Company (2024)
 Figure 34. Global 5 Largest Liraglutide Players Market Share by Revenue in Liraglutide: 2020 & 2024
 Figure 35. Liraglutide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 36. Manufacturing Cost Structure of Liraglutide
 Figure 37. Manufacturing Process Analysis of Liraglutide
 Figure 38. Liraglutide Industrial Chain
 Figure 39. Channels of Distribution (Direct Vs Distribution)
 Figure 40. Distributors Profiles
 Figure 41. Bottom-up and Top-down Approaches for This Report
 Figure 42. Data Triangulation
 Figure 43. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4250

This license allows only one user to access the PDF.
Electronic (PDF)

$6000

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$8000

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions